Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Oxford Immunotec Global PLC
| Metric | Oxford Immunotec Global PLC Healthcare |
|---|---|
| Quality Score | 43 / 100 |
| Revenue (latest) | $74M |
| Net income (latest) | −$2M |
| Operating margin | −8.3% |
| Net margin | −2.5% |
| Return on equity | −0.8% |
| Return on assets | −0.8% |
| Return on capital (ROCE) | −2.8% |
| Debt / equity | 0.10× |
| Revenue growth (YoY) | 23.4% |
| Altman Z″ (distress) | 14.70 |
| Accruals / assets | 2.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.